Apricitabine

What is apricitabine?

Apricitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).

Avexa Announces End to Development of Experimental NNRTI Apricitabine
5-11-2010

Newer Anti-HIV Drugs and How to Use Them: Part I
6-23-2009

Safety Monitoring Board Says Phase 3 Trial of Experimental NRTI Apricitabine Can Go Forward Using Lower Dose
6-16-2009

New NRTI Apricitabine Demonstrates Good Safety in Early Clinical Trial
8-22-2008

Apricitabine Effective Against Drug-resistant HIV
8-01-2008